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I

n this issue, McCall1 has commented that their study2 was
incorrectly excluded from our systematic review,3 based on
our assessment that polysomnography (PSG) was not used to
diagnose obstructive sleep apnea (OSA) in their depressed participants, when in fact PSG had been used to diagnose OSA
in their ﬁnal study sample. The goal of our systematic review
was to examine the prevalence of OSA diagnosed by PSG
in individuals with schizophrenia and other psychotic disorders, mood disorders, and anxiety disorders.3 Ideally, the goal
was to examine prevalence in psychiatric populations where
all individuals included in the study had a clinical psychiatric diagnosis and were assessed for the OSA using PSG. Our
rationale for excluding the McCall study,2 where participants
with symptoms of OSA were excluded via interview without
PSG, was more complex than a simple table in the appendix
could convey and was the subject of signiﬁcant debate between
the authors. In many ways, this demonstrates the subjective
problem of integrating many studies with diverse aims into the
speciﬁc aims of a systematic review. McCall is correct that a
subset of the population studied in their article included patients with MDD and insomnia with OSA diagnosed by PSG,
which does ﬁt the letter of our inclusion criteria.2,3 However, in
the spirit of examining OSA prevalence in the full psychiatric
population, the rationale for excluding the study was based on
the two-part screening procedure. McCall et al. conducted an
initial telephone interview, which was used to exclude potential
participants with an existing diagnosis or strong signs of OSA
without a PSG.2 This is a study design that makes perfect sense
for identifying ideal participants to study the risks of OSA in
low-risk MDD patients with insomnia; however, we felt it was
problematic, based on the aims of our study, to exclude patients
with existing or probable OSA without PSG. It was our conclusion that the active exclusion of known individuals with OSA
biased the study in such a way as to make the data inappropriate for inclusion in a study on global prevalence. This was a
subjective decision and in hindsight, we should have erred on
the side of inclusivity with our screening process and discussed
the screening process as a potential source of sample bias.
We are glad that this review has opened a discussion on
the importance of assessing treatment-refractory psychiatric
patients for sleep disorders using PSG. McCall et al. provide

strong evidence that OSA can be present in even the lowest
risk MDD patients.2 The ﬁndings of McCall et al. also suggest that insomnia and OSA are not necessarily independent
conditions, especially in patients with autonomic dysregulation at the primary central nervous level, such as in some psychiatric patients. Different levels of autonomic nervous system
activation and resultant hyperarousal and sleep fragmentation
could result in varying levels of insomnia in OSA patients with
psychiatric disorders. It is therefore possible that levels of insomnia in the psychiatric patient with OSA vary over time, depending upon the severity of the psychiatric disorder and level
of autonomic activation. This underscores the importance of
considering sleep fragmentation as a principal component of
the neurological, metabolic, and biologic factors contributing
to severity and treatment resistance in psychiatric disorders.
We hope that this information will spur the increased use of
PSG as a part of the psychiatric diagnostic toolkit.
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